C-Path
News & Events
-
October 1, 2016
Development of a symptom-based patient-reported outcome instrument for functional dyspepsia: A preliminary conceptual model and an evaluation of the adequacy of existing instruments
Taylor F, Reasner DS, Carson RT, Deal LS, Foley C, Iovin R, Lundy JJ, Pompilus F, Shields AL, Silberg DG. Development of a symptom-based patient-reported outcome instrument for functional dyspepsia: a preliminary conceptual model and an evaluation of the adequacy of existing instruments. The Patient – Patient-Centered Outcomes Research 2016;9(5):409-418.
-
October 1, 2016
Development of a patient-reported outcome (PRO) instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase
Gordon MF, Lenderking WR, Duhig A, Chandler J, Lundy JJ, Miller DS, et al. Development of a patient-reported outcome (PRO) instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: the qualitative research phase. 2015;12(1):75–84.
-
October 1, 2016
Population-Based Resistance of Mycobacterium Tuberculosis Isolates to Pyrazinamide and Fluoroquinolones: Results from a Multicountry Surveillance Project
Zignol M, Dean AS, Alikhanova N, Andres S, Cabibbe AM, Cirillo DM, Dadu A, Dreyer A, Driesen M, Gilpin C, Hasan R, Hasan Z, Hoffner S, Husain A, Hussain A, Ismail N, Kamal M, Mansjö M, Mvusi L, Niemann S, Omar SV, Qadeer E, Rigouts L, Ruesch-Gerdes S, Schito M, Seyfaddinova M, Skrahina A, Tahseen S, Wells WA, Mukadi YD, Kimerling M, Floyd K, Weyer K, Raviglione MC. Population-Based Resistance of Mycobacterium Tuberculosis Isolates to Pyrazinamide and Fluoroquinolones: Results from a Multicountry Surveillance Project. The Lancet Infectious Diseases. 2016 Oct;16(10):1185–92.
-
September 29, 2016
The International Neonatal Consortium: Collaborating to Advance Regulatory Science for Neonates
Turner MA, Davis JM, McCune S, Bax R, Portman RJ, Hudson, LD. “The International Neonatal Consortium Collaborating to Advance Regulatory Science for Neonates.” Pediatric Research 80(4): 462-463 (2016).... -
September 16, 2016
Evaluation of Cardiac Toxicity Biomarkers in Rats from Different Laboratories
Kim K, Chini N, Fairchild DG, Engle SK, Reagan WJ, Summers SD, Mirsalis JC, Cardiac Hypertrophy Working Group of the Predictive Safety Testing Consortium. Evaluation of Cardiac Toxicity Biomarkers in Rats from Different Laboratories. Toxicologic Pathology. 2016 Sep 16.